@sa
ABS-201 is a groundbreaking hair loss injectable developed by Absci, a company based in Vancouver, Washington, that is leveraging AI to create revolutionary new medications.
Getting a drug into clinical trials typically takes around five years and as much as $100 million, whereas the new injectable took just 24 months to develop at a cost of $15 million.
https://www.popularmechanics.com/science/health/a69077094/new-hair-regrowth-treatment/